Lyfegen Raises CHF 750K in Seed Funding

LyfegenLyfegen HealthTech AG, a Basel, Switzerland-based a healthcare technology company, closed its seed financing round, raising a total of CHF750k.

The round was led by Swiss private investors.

The company intends to use the funds to further build its payments platform and conduct further pilots with partners in the US, Africa, and the EU, including the UK.

Founded in October 2018 by Girisha Fernando, Michel Mohler, Nico Mros, Leon Rebolledo and James Gannon, Lyfegen HealthTech is a healthcare technology company that has developed a platform which collects, analyzes and reconciles disparate healthcare data for the purpose of automating value-based healthcare contracting. The solution enables life sciences companies, national and private healthcare payers and healthcare providers to operationalize healthcare strategies whilst benefiting from a single solution for their operations.
In addition, the system allows for personalized healthcare by enabling patient level pricing, fostering accelerated and facilitated access to innovative treatments for patients.



Join the discussion